Evaluation of Safety, Tolerability, and Pharmacodynamic Effects of Topically Applied SUDO-286 in Psoriasis

2023-509079-18-00 Protocol SUDO-286-101 Human pharmacology (Phase I) - Other Ended

Start 22 Jul 2024 · End 25 Apr 2025 · Status Ended · 1 EU/EEA countries · 4 sites · Protocol SUDO-286-101

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ended
Participants planned 15
Countries 1
Sites 4

Plaque Psoriasis

Key facts

Sponsor
Sudo Biosciences Limited
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Skin and Connective Tissue Diseases [C17]
Trial duration
22 Jul 2024 → 25 Apr 2025
Decision date (initial)
2024-06-24
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Plaque Psoriasis

VersionLevelCodeTermSystem organ class
20.0 LLT 10071117 Plaque psoriasis 10040785

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Sudo Biosciences Limited

Sponsor organisation
Sudo Biosciences Limited
Address
3rd Floor, 1 Ashley Road 1 Ashley Road
City
Altrincham
Postcode
WA14 2DT
Country
United Kingdom

Scientific contact point

Organisation
Sudo Biosciences Limited
Contact name
Ian Mills

Public contact point

Organisation
Sudo Biosciences Limited
Contact name
Kejal Patel

Locations

1 EU/EEA country · 4 investigational sites

By country

CountryMS statusPlanned subjectsSites
Germany Ended 15 4
Rest of world 0

Investigational sites

Germany

4 sites · Ended
Klinische Forschung Schwerin GmbH
Practice, Friedrichstrasse 1, Altstadt, Schwerin
Dr. Niesmann And Dr. Othlinghaus GbR
Practice, Alleestrasse 80, Innenstadt, Bochum
Fachaerztliche Gemeinschaftspraxis fuer Dermatologie Und Venerologie Allergologie Umweltmedizin Lasermedizin GbR
Practice, Am Bahnhof 1, Mahlow, Blankenfelde-Mahlow
Eurofins bioskin GmbH
Research Center Dermatology, Messberg 4, Hamburg-Altstadt, Hamburg

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Germany 2024-07-22 2024-08-05 2025-04-25

Application history

3 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-04-29 Germany Acceptable
2024-06-21
2024-06-24
2 SUBSTANTIAL MODIFICATION SM-1 2024-12-05 Germany Acceptable
2024-12-23
2025-01-13
3 NON SUBSTANTIAL MODIFICATION NSM-1 2025-03-24 Germany Acceptable
2024-12-23
2025-03-24